ANN ARBOR, Mich.--(BUSINESS WIRE)--RetroSense Therapeutics, a privately-held biopharmaceutical company, today announced that Chief Executive Officer Sean Ainsworth will provide an overview of the Company’s approach to vision restoration at the 8th Ocular Diseases Drug Discovery Conference at the Westin Hotel in San Diego, CA. The presentation, entitled Novel Optogenetic Approach to Vision Restoration in Retinal Degenerative Conditions, will take place at 2:45 p.m. PDT on Monday, March 21, 2016.
